BIONOMICS
Bionomics Limited engages in the discovery and development of therapeutics for cancer and diseases of the central nervous system in Australia. It has small molecule product development programs in the areas of cancer, anxiety, epilepsy, and multiple sclerosis. The company develops its lead cancer compound, BNC 105, for the treatment of solid tumors, such as breast, lung, colon, and prostate cancers. BNC 105 is a member of the class of compounds, known as vascular disruption agents or VDAs, which... shut down the blood supply within a tumor, starving the tumor and preventing its continued growth. The company has commercial partnerships with Genmab A/S; Athena Diagnostics; Laboratory Corporation of America; and Genetic Technologies, Ltd. Bionomics Limited was founded in 1999 and is based in Thebarton, Australia.
BIONOMICS
Industry:
Biotechnology Health Diagnostics Medical
Founded:
1999-01-01
Address:
Thebarton, South Australia, Australia
Country:
Australia
Website Url:
http://www.bionomics.com.au
Total Employee:
11+
Status:
Active
Contact:
61 8 8354 6100
Email Addresses:
[email protected]
Total Funding:
38.64 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Vulcan Biosciences
Vulcan Biosciences commercializes a therapy for treating multiple sclerosis (MS), a debilitating disease of the central nervous system.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-09-23 | Prestwick Chemical | Prestwick Chemical acquired by Bionomics | N/A |
| 2012-09-17 | Eclipse Therapeutics | Eclipse Therapeutics acquired by Bionomics | 10 M USD |
| 2005-05-24 | Iliad Chemicals Pty | Iliad Chemicals Pty acquired by Bionomics | 6.1 M AUD |
Investors List
Novamind
Novamind investment in Post-IPO Equity - Bionomics
Start-up Australia Ventures
Start-up Australia Ventures investment in Post-IPO Equity - Bionomics
Official Site Inspections
http://www.bionomics.com.au Semrush global rank: 6.43 M Semrush visits lastest month: 1.02 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Bionomics"
Bionomics - Crunchbase Company Profile & Funding
Bionomics discovers and develops therapeutics for cancer and diseases of the central nervous system.See details»
Bionomics Company Profile | Management and Employees List
Bionomics Profile and History Bionomics is a global, clinical stage bio-pharmaceutical company leveraging its proprietary platform technologies to discover and develop a deep pipeline of โฆSee details»
Bionomics Investor Presentation - monsoon.com.au
Bionomics Investor Presentation Bionomics Limited (ASX: BNO, OTCQB: BNOEF) (Bionomics or Company), a global, clinical stage biopharmaceutical company, is pleased to provide an โฆSee details»
Bionomics Ltd ADR (BNOX-Q) Profile - The Globe and Mail
Dec 24, 2024 See the company profile for Bionomics Ltd ADR (BNOX-Q) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
BIONOMICS LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BIONOMICS LTD of EASTWOOD, SOUTH AUSTRALIA. Get the latest business insights from Dun & โฆSee details»
Bionomics - Overview, News & Similar companies | ZoomInfo.com
Oct 29, 2023 View Bionomics (www.bionomics.com.au) location in South Australia, Australia , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
Bionomics Ltd - BIO International Convention 2025
Bionomics (NASDAQ:BNOX) is a clinical-stage biotechnology company that is developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious and โฆSee details»
Bionomics Company Profile - Office Locations, Competitors, โฆ
Aug 28, 2023 Bionomics has 1 employees at their 1 location and $264 k in annual revenue in FY 2022. See insights on Bionomics including office locations, competitors, revenue, financials, โฆSee details»
Bionomics Limited - Cruelty Free Investing
Bionomics Ltd operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a pipeline of novel therapeutic ion channel targeting drug candidates to improve โฆSee details»
Bionomics Limited โ Funding, Valuation, Investors, News
Dec 16, 2024 Essential stats, news, real-time insights on Bionomics Limited. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews.See details»
Bionomics Reminds Shareholders to Cast their Vote for
Dec 2, 2024 Bionomics (NASDAQ: BNOX) is a clinical-stage biotechnology company developing novel, potential first-in-class, allosteric ion channel modulators to treat patients suffering from โฆSee details»
9. Bionomics - AusBiotech Ltd
Bionomics is a fully integrated, international drug discovery and development company creating new therapies that serve large unmet needs in cancer and central nervous system (CNS) โฆSee details»
Bionomics Provides an Update on Re-domiciliation via Scheme of โฆ
Nov 8, 2024 ADELAIDE, Australia and CAMBRIDGE, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage โฆSee details»
Bionomics Receives Milestone Payment of AUS$1M from Carina โฆ
Nov 4, 2024 Based on the agreement, Bionomics is eligible to receive up to approximately AUS$118 million in certain development, regulatory and commercial milestone payments if โฆSee details»
Results of Scheme Meeting - GlobeNewswire
Dec 12, 2024 Bionomics shareholders have today approved, by the requisite majority, the proposed Scheme of Arrangement in relation to the Companyโs proposed re-domiciliation from โฆSee details»
Bionomics - teaserclub.com
Bionomics Limited is a clinical-stage biopharmaceutical company based in Thebarton, Australia, specializing in the discovery and development of novel therapeutics for central nervous system โฆSee details»
Bionomics Announces Supreme Court of New South Wales
Dec 16, 2024 ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to โฆSee details»
Bionomics Reminds Shareholders to Cast their Vote for Re
Dec 2, 2024 --Bionomics Limited, a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central โฆSee details»
Bionomics Reminds Shareholders to Cast their Vote for Re โฆ
Dec 2, 2024 Bionomics is advancing its lead drug candidate, BNC210, an oral, proprietary, selective negative allosteric modulator of the ฮฑ7 nicotinic acetylcholine receptor, for the acute โฆSee details»
Bionomics Receives Milestone Payment of AUS$1M from Carina
Nov 4, 2024 Bionomics (NASDAQ: BNOX) is a clinical-stage biotechnology company developing novel, potential first-in-class, allosteric ion channel modulators to treat patients suffering from โฆSee details»